Skip to main content
. 2023 Jun 15;13:1146905. doi: 10.3389/fonc.2023.1146905

Figure 2.

Figure 2

Forest plot of hazard ratio (HR). Comparison of overall survival (OS) (A) and progression-free survival (PFS) (B) between dual immunotherapy and chemotherapy depending on PD-L1 expression level.